NCT02134795

Brief Summary

This is a single-center, open label study evaluating the acute effect of caloric vestibular stimulation on UPDRS motor scores in Parkinson's Disease patients.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2014

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2014

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

May 6, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 9, 2014

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2014

Completed
10.7 years until next milestone

Results Posted

Study results publicly available

May 2, 2025

Completed
Last Updated

May 2, 2025

Status Verified

April 1, 2025

Enrollment Period

4 months

First QC Date

May 6, 2014

Results QC Date

March 25, 2025

Last Update Submit

April 30, 2025

Conditions

Keywords

Parkinson's disease

Outcome Measures

Primary Outcomes (1)

  • Motor UPDRS Score (Unified Parkinson's Disease Rating Scale)

    A motor score prior to use of the device will be established (time zero), the motor test will be repeated after the first use of the device (times 25, 50, and 75 minutes), and then after a second use of the device (times 100, 130, 160 and 220). Any changes in motor scores at the various time points will be noted. A videotape of the motor UPDRS examination will be obtained at baseline and during the final test.

    Changes in motor score at 25, 50, 75, 100, 130, 160 and 220 minutes relative to baseline

Study Arms (1)

Caloric Vestibular Stimulation (CVS)

EXPERIMENTAL

Mild to moderate Parkinson's disease subjects will up to 3 sessions of 19 minutes each with the TNM Device during as many as 2 study visits: 2 sessions separated by 1 hour during the 1st study visit and 1 CVS session during a 2nd study visit.

Device: TNM Device

Interventions

The noninvasive device is worn like a music headset and the patient lies back on a wedge pillow while the device is active. Each session lasts under 20 minutes.

Caloric Vestibular Stimulation (CVS)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient should have a UPDRS motor score of 14 (off medication) or higher (mild to moderate)
  • Patient should have a Hoehn \& Yahr staging of 1 to 3 (mild to moderate)
  • Patient must be an adult (18 years of age or older)

You may not qualify if:

  • Women who are pregnant or nursing
  • have a history of significant cardiovascular disease (no pacemakers)
  • have a history of unstable mood disorder or unstable anxiety disorder or psychosis
  • use a hearing aid
  • have a cochlear implant
  • have been diagnosed with neurological disease other than Parkinson's disease. No atypical parkinsonism.
  • have a diagnosed vestibular dysfunction
  • abuse alcohol or other drugs
  • have had eye surgery within the previous three months or ear surgery within the previous six months
  • have active ear infections or a perforated tympanic membrane
  • have participated in another clinical trial within the last 30 days or are currently enrolled in another clinical trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke University Health System

Durham, North Carolina, 27705, United States

Location

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Limitations and Caveats

The study did not achieve full enrollment and was, therefore, halted. This occurred before participants were able to complete outcomes measures, and, therefore, prevented outcome analysis.

Results Point of Contact

Title
Dr. Robert Black
Organization
Scion NeuroStim

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 6, 2014

First Posted

May 9, 2014

Study Start

May 1, 2014

Primary Completion

September 1, 2014

Study Completion

September 1, 2014

Last Updated

May 2, 2025

Results First Posted

May 2, 2025

Record last verified: 2025-04

Locations